T1	CHEM 62 68	DAY101
T2	PROC 81 103	quimioterapia estándar
T3	LIVB 107 128	pacientes pediátricos
T4	Age 117 128	pediátricos
T5	DISO 133 153	glioma de bajo grado
#1	AnnotatorNotes T5	C1997217; Low grade glioma; Neoplastic Process
T6	PROC 167 205	tratamiento sistémico de primera línea
T7	PROC 245 308	Ensayo en fase III, aleatorizado, internacional y multicéntrico
T8	CHEM 312 318	DAY101
T9	PROC 322 333	monoterapia
#2	AnnotatorNotes T9	C4763675; Single Agent Therapy; Therapeutic or Preventive Procedure
T10	PROC 346 368	quimioterapia estándar
T11	LIVB 372 381	pacientes
#3	AnnotatorNotes T11	C0030705; Patients; Patient or Disabled Group
T12	DISO 386 417	glioma pediátrico de bajo grado
T13	PROC 478 516	tratamiento sistémico de primera línea
T14	DISO 538 552	Tumor cerebral
#4	AnnotatorNotes T14	C0006118; Brain Neoplasms; Neoplastic Process
T15	LIVB 556 561	niños
#5	AnnotatorNotes T15	C0008059; Child; Age Group | C0870221; Boys; Age Group
T16	Age 556 561	niños
T17	LIVB 564 579	adultos jóvenes
T18	Age 564 579	adultos jóvenes
T19	PROC 594 605	tratamiento
#6	AnnotatorNotes T19	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T20	DISO 646 677	Glioma pediátrico de bajo grado
T21	PROC 737 775	tratamiento sistémico de primera línea
T22	Age 809 827	inferior a 25 años
T23	DISO 830 850	glioma de bajo grado
#7	AnnotatorNotes T23	C1997217; Low grade glioma; Neoplastic Process
T24	PROC 891 918	Diagnóstico histopatológico
T25	DISO 922 928	glioma
#8	AnnotatorNotes T25	C0017638; Glioma; Neoplastic Process
T26	DISO 931 949	tumor glioneuronal
T27	DISO 966 980	lesión medible
T28	PROC 1054 1092	tratamiento sistémico de primera línea
T29	DISO 1196 1201	tumor
#9	AnnotatorNotes T29	C0027651; Neoplasms; Neoplastic Process | C0038999; Swelling; Finding
T30	DISO 1207 1217	Schwannoma
#10	AnnotatorNotes T30	C0027809; Neurilemmoma; Neoplastic Process
T31	DISO 1222 1268	Astrocitoma subependimario de células gigantes
#11	AnnotatorNotes T31	C0205768; Subependymal Giant Cell Astrocytoma; Neoplastic Process
T32	DISO 1270 1289	Esclerosis Tuberosa
#12	AnnotatorNotes T32	C0041341; Tuberous Sclerosis; Neoplastic Process
T33	DISO 1295 1327	Glioma pontino intrínseco difuso
#13	AnnotatorNotes T33	C2986658; Diffuse Intrinsic Pontine Glioma; Neoplastic Process
T34	PROC 1343 1366	diagnóstico histológico
T35	DISO 1462 1467	tumor
#14	AnnotatorNotes T35	C0027651; Neoplasms; Neoplastic Process | C0038999; Swelling; Finding
T36	PROC 1471 1482	Diagnóstico
#15	AnnotatorNotes T36	C0011900; Diagnosis; Diagnostic Procedure
T37	Spec_cue 1494 1502	presunto
T38	DISO 1506 1537	neurofibromatosis de tipo 1 o 2
T39	Speculated 1506 1537	neurofibromatosis de tipo 1 o 2
T40	DISO 1539 1543	NF-1
#16	AnnotatorNotes T40	C0027831; Neurofibromatosis 1; Neoplastic Process
T41	Speculated 1539 1543	NF-1
T42	DISO 1544 1548	NF-2
#17	AnnotatorNotes T42	C0027832; Neurofibromatosis 2; Neoplastic Process
T43	Speculated 1544 1548	NF-2
T44	PROC 1553 1593	Tratamiento antineoplásico no quirúrgico
T45	Negated 1583 1593	quirúrgico
T46	PROC 1644 1657	quimioterapia
#18	AnnotatorNotes T46	C0013216; Pharmacotherapy; Therapeutic or Preventive Procedure | C0392920; Chemotherapy Regimen; Therapeutic or Preventive Procedure | C3665472; Chemotherapy; Therapeutic or Preventive Procedure
T47	PROC 1659 1677	terapias dirigidas
#19	AnnotatorNotes T47	C0278348; Immunotherapy for cancer; Therapeutic or Preventive Procedure
T48	Route 1682 1690	vía oral
T49	Route 1693 1696	i.v
T50	PROC 1712 1724	radioterapia
#20	AnnotatorNotes T50	C0041626; Ultraviolet Therapy; Therapeutic or Preventive Procedure | C1522449; Therapeutic radiology procedure; Therapeutic or Preventive Procedure
T51	Date 12 16	2022
T52	DISO 695 723	alteración de RAF activadora
T53	DISO 436 464	alteración de RAF activadora
T54	DISO 859 887	alteración de RAF activadora
T55	PROC 1007 1021	criterios RANO
T56	DISO 1419 1455	alteraciones moleculares activadoras
T57	Neg_cue 1580 1582	no
T58	Route 179 188	sistémico
T59	Route 490 499	sistémico
T60	Route 749 758	sistémico
T61	Route 1066 1075	sistémico
T62	Quantifier_or_Qualifier 454 464	activadora
T63	Quantifier_or_Qualifier 606 621	por primera vez
T64	Quantifier_or_Qualifier 713 723	activadora
T65	Quantifier_or_Qualifier 953 965	Al menos una
T66	CONC 1007 1021	criterios RANO
T67	Quantifier_or_Qualifier 1079 1092	primera línea
T68	Observation 1161 1183	hallazgos histológicos
T69	Quantifier_or_Qualifier 1373 1383	grado I-II
T70	Quantifier_or_Qualifier 1444 1455	activadoras
T71	Patient 107 128	pacientes pediátricos
T72	Patient 372 381	pacientes
T73	Patient 556 561	niños
T74	Patient 564 579	adultos jóvenes
T75	History_of 1506 1537	neurofibromatosis de tipo 1 o 2
T76	History_of 1539 1543	NF-1
T77	History_of 1544 1548	NF-2
T78	History_of 1553 1593	Tratamiento antineoplásico no quirúrgico
T79	History_of 1644 1657	quimioterapia
T80	History_of 1659 1677	terapias dirigidas
